ASX - Delayed Quote AUD
Neuren Pharmaceuticals Limited (NEU.AX)
At close: October 18 at 4:10 PM GMT+11
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 6 | 6 |
| Avg. Estimate | 0 | 0 | 0.66 | 0.82 |
| Low Estimate | 0 | 0 | 0.51 | 0.32 |
| High Estimate | 0 | 0 | 0.85 | 1.15 |
| Year Ago EPS | -- | -- | 1.2 | 0.66 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 6 | 6 |
| Avg. Estimate | -- | -- | 143.65M | 180.62M |
| Low Estimate | -- | -- | 115.4M | 118.72M |
| High Estimate | -- | -- | 189.9M | 251.7M |
| Year Ago Sales | -- | -- | 231.93M | 143.65M |
| Sales Growth (year/est) | -- | -- | -38.10% | 25.70% |
Earnings History
| CURRENCY IN USD | |
|---|---|
| EPS Est. | -- |
| EPS Actual | -- |
| Difference | -- |
| Surprise % | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0.66 | 0.82 |
| 7 Days Ago | 0 | 0 | 0.66 | 0.82 |
| 30 Days Ago | 0 | 0 | 0.72 | 0.77 |
| 60 Days Ago | 0 | 0 | 0.72 | 0.77 |
| 90 Days Ago | 0 | 0 | 0.73 | 0.75 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| CURRENCY IN USD | NEU.AX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 3.70% |
| Next Qtr. | -- | -- | -- | 7.90% |
| Current Year | -45.00% | -- | -- | 2.50% |
| Next Year | 24.20% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.88% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
CU6.AX Clarity Pharmaceuticals Ltd
6.78
+4.15%
TLX.AX Telix Pharmaceuticals Limited
21.96
+4.57%
DXB.AX Dimerix Limited
0.4500
-8.16%
LTP.AX LTR PHARMA FPO [LTP]
1.6250
-1.81%
IMM.AX Immutep Limited
0.3000
-1.64%
MSB.AX Mesoblast Limited
1.4500
-2.03%
PAA.AX Neurizon Therapeutics Limited
0.2300
0.00%
CUV.AX Clinuvel Pharmaceuticals Limited
13.90
-1.42%
BOT.AX Botanix Pharmaceuticals Limited
0.3450
-1.43%
NSB.AX NeuroScientific Biopharmaceuticals Limited
0.0390
-4.88%